Ovarian Cancer Awareness Month
Ovarian cancer encompasses cancers of the ovaries, fallopian tubes, and the primary peritoneum, which is the tissue that lines the abdominal wall and covers the abdominal organs. Taken together, this group is the fifth leading cause of cancer death in women in the United States.
These cancers often go undetected until they’ve reached advanced stages. They may not cause early signs or symptoms, and it is difficult to screen for the disease, according to the National Cancer Institute.
Ovarian cancer is rare – about 1.3 percent of women will be diagnosed with ovarian cancer at some point in their life, according to data from the NCI’s Surveillance, Epidemiology, and End Results Program. An estimated 22,530 women in the United States will be diagnosed with ovarian cancer and 13,980 will die from the disease in 2019.
But because it often goes untreated until the disease has advanced, the survival rate is low, with a five-year survival rate of 47.6 percent.
There are three types of ovarian cancer in adults. Ovarian epithelial cancer begins in the tissue covering the ovary, lining the fallopian tube, or the peritoneum. Ovarian germ cell tumors start in the egg or germ cells. Ovarian low malignant potential tumors begin in the tissue covering the ovary, and are characterized by abnormal cells that may become cancer, but usually do not.
Risk factors for developing ovarian cancer include family history and the presence of inherited gene mutations. There are tests that can detect mutations in the BRCA1 and BRCA2 genes, which increase the risk of female breast and ovarian cancers and some additional types of cancer. Other risk factors include the use of estrogen-only hormone replacement therapy and the use of fertility drugs.
September is Ovarian Cancer Awareness Month.
Ovarian Cancer-Focused Conference
In September, the AACR and the Rivkin Center for Ovarian Cancer will present the special conference Advances in Ovarian Cancer Research. The conference will focus on advances in ovarian cancer research and treatment, exploring the latest basic and translational research in the field and the applications of this research to the development of therapeutic options and the treatment of women with ovarian cancer.
Grants and Awards
The following 2019 awards went to investigators whose studies focused on various aspects of ovarian cancers:
2019 AACR Scholar-in-Training Award
- Justyna E. Kanska, PhD, Cedars-Sinai Medical Center
2019 AACR-Bristol-Myers Squibb Oncology Scholar-in-Training Award
- Sarah J. Hill, MD, PhD, Dana-Farber Cancer Institute
2019 AACR Margaret Foti Scholar-in-Training Award
- Zhiyuan Hu, University of Oxford (UK)
2019 AACR-Pezcoller Foundation Scholar-in-Training Award
- Robert L. Hollis, PhD, University of Edinburgh (UK)
2019 AACR-SIC Scholar-in-Training Awards
- Marco Giordano, PhD, European Institute of Oncology (Italy)
2019 AACR Minority and Minority-Serving Institution Faculty Scholars in Cancer Research
- Luciana Madeira da Silva, PhD, University of South Alabama
2019 AACR Minority Scholar in Cancer Research Award
- Anita M. Chanana, BS, Stanford University School of Medicine
- Claudia B. Colon-Echevarria, MPH, Ponce Health Sciences University (Puerto Rico)
- Janice M. Santiago-Ofarrill, PhD, The University of Texas MD Anderson Cancer Center